Saturday 17 October 2026
Export PTIX’s income statement to Excel — free account
Atrinsic Inc.
PTIX Healthcare Biotechnology
In the quarter to June 2026, EPS grew 61.3% and free cash flow grew 46.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.75
0.05
−6.25%
Follow PTIX
| Mar '26 | Mar '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
1.50 | 0.02 | 2.00 | 6.41 | 7.18 | 13.83 | 1.34 | 0.70 | 0.77 | 3.17 |
Net Debt/EBITDA |
0.52 | 0.01 | 0.33 | 0.92 | 2.31 | 2.71 | (0.29) | 0.25 | 0.26 | 0.71 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.88% | 156.26% | 33.17% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | (1.19) | (0.44) | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
(2.05) | 0.49 | 0.76 | 0.74 | 0.56 | 0.62 | 0.53 | 0.28 | 0.42 | 0.61 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (1.31) | (0.02) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
(3.01) | (2.50) | — | (42.03) | (25.87) | (8.33) | (10.36) | (131.20) | (826.46) | (170.17) |
| (117.22%) | 182.34% | (236.06%) | (94.48%) | (42.18%) | (102.88%) | 285.71% | 414.27% | (507.24%) | (122.26%) | |
| 73.16% | (351.29%) | (175.98%) | (80.91%) | (37.24%) | (75.77%) | (296.10%) | (227.51%) | (206.42%) | (91.43%) | |
ROIC |
(253.66%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
260.22% | 72.52% | (545.39%) | (136.33%) | (51.40%) | (44.08%) | (1,137.81%) | 493.21% | 1,212.66% | (185.32%) |
Average Days of Receivables |
— | 0.00 | — | — | — | — | — | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(1.21) | (0.33) | (12.05) | (12.42) | (6.47) | (10.64) | (7.31) | (2.66) | (5.85) | (7.53) |
Cash per Share |
0.65 | 0.00 | 5.25 | 13.08 | 25.88 | 39.42 | 3.64 | 4.36 | 3.35 | 9.20 |
Shareholders Equity per Share |
1.12 | (0.92) | 2.90 | 11.83 | 22.44 | 37.79 | (6.23) | (3.46) | (1.15) | 6.66 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.12 | (0.92) | 2.90 | 11.83 | 22.44 | 37.79 | (6.23) | (3.46) | (1.15) | 6.66 |
Free Cash Flow |
(2.81) | (1.77) | (4.22) | (3.85) | (2.00) | (2.80) | (1.35) | (0.49) | (1.07) | (1.38) |
Working Capital |
0.51 | (4.95) | 0.94 | 3.54 | 6.92 | 10.26 | 0.22 | (0.36) | (0.21) | 1.22 |
Capital Expenditures |
0.00 | — | — | (0.15) | 0.00 | — | — | — | — | — |
Net Current Asset Value |
0.51 | (4.95) | 0.94 | 3.54 | 6.92 | 9.94 | (1.15) | (0.63) | (0.21) | 1.22 |
| Other line items | ||||||||||
Quick Ratio |
1.46 | 0.02 | 1.95 | 6.19 | 7.12 | 12.97 | 1.02 | 0.67 | 0.68 | 3.00 |
Depreciation/Fixed assets |
110.73 | 0.00 | 0.69 | 0.92 | 61.56 | 0.00 | 0.00 | 39.00 | 0.50 | 0.10 |
Cash ROIC |
(68.07%) | 35.82% | (147.86%) | (49.89%) | (13.40%) | (13.56%) | (150.67%) | (110.01%) | (266.47%) | (47.51%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | 0.00 | — | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(1.21) | (0.33) | (12.05) | (11.94) | (6.47) | (10.64) | (7.31) | (2.66) | (5.85) | (7.53) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.48) | (0.01) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
0.96 | 0.95 | 0.80 | 0.72 | 0.79 | 0.69 | 0.72 | 0.55 | 0.18 | 0.15 |
Average Assets |
1.87 | 1.02 | 3.14 | 6.18 | 9.55 | 5.97 | 0.86 | 0.77 | 1.24 | 2.47 |
Average Common Equity |
(1.17) | (1.97) | 2.34 | 5.29 | 8.43 | 4.40 | (0.89) | (0.42) | 0.50 | 1.85 |
Capex to Sales |
0.00 | — | — | 0.00 | 0.00 | — | — | — | — | — |
Columns are period end dates · fundamentals updated 28 Sep 2026